Filter
2491
Filtered Results: 2491
Text search:
adverse
events
Featured
Recommendations
281
New Publications
611
Language
Document type
No document type
1294
Guidelines
426
Studies & Reports
409
Manuals
156
Strategic & Response Plan
80
Fact sheets
54
Training Material
42
Situation Updates
13
Infographics
5
Resource Platforms
4
Online Courses
4
Brochures
2
Videos
2
Countries / Regions
India
108
Global
101
South Africa
59
Western and Central Europe
57
Kenya
53
Ethiopia
46
Latin America and the Carribbean
40
Africa
36
Uganda
34
Nepal
33
Ghana
32
Nigeria
30
Tanzania
30
Bangladesh
28
Zambia
26
Philippines
24
Myanmar / Burma
24
Sierra Leone
23
Malawi
23
Ukraine
22
Liberia
19
Rwanda
19
Eastern Europe
19
South–East Asia Region
18
Cambodia
17
Namibia
15
Syria
13
USA
12
South Sudan
12
Brazil
12
Zimbabwe
11
Colombia
10
East and Southern Africa
10
Guinea
9
Lesotho
9
Asia
9
Senegal
8
Mozambique
8
Eastern Europe and Central Asia
8
Congo, Democratic Republic of
7
Haiti
7
Germany
7
Indonesia
7
Eswatini/ Swaziland
7
Chile
7
Venezuela
7
Russia
7
West and Central Africa
6
Pakistan
5
Afghanistan
5
Thailand
5
Ecuador
5
Botswana
5
Middle East and North Africa
5
Western Pacific Region
5
Cameroon
4
Yemen
4
Burkina Faso
3
Somalia
3
Jordan
3
Lebanon
3
China
3
Sudan
3
Argentina
3
Angola
3
Sri Lanka
3
Paraguay
3
Palestine
3
Laos
3
Moldova
3
Mali
2
Niger
2
Egypt
2
Central African Republic
2
North Macedonia
2
El Salvador
2
Madagascar
2
Other region
2
Bhutan
2
Timor Leste/ East Timor
2
Kyrgyzstan
2
Vietnam
2
North America
2
Belarus
2
Guinea-Bissau
1
Iraq
1
Chad
1
Gambia
1
Mauritania
1
Ireland
1
Peru
1
Burundi
1
Honduras
1
Bolivia
1
Poland
1
Albania
1
Djibouti
1
Southern Africa
1
Canada
1
Tajikistan
1
Romania
1
Lithuania
1
Iran
1
Australia
1
Kazakhstan
1
Georgia
1
Turkmenistan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
735
Clinical Guidelines
310
Public Health
151
Women & Child Health
128
Key Resources
124
Capacity Building
45
Pharmacy & Technologies
19
Toolboxes
Mental Health
287
COVID-19
232
HIV
165
TB
159
Planetary Health
146
Rapid Response
78
Caregiver
73
Pharmacy
69
AMR
62
NTDs
61
NCDs
56
Conflict
54
Ebola
51
Global Health Education
49
Disability
38
Refugee
38
Natural Hazards
29
Specific Hazards
26
Polio
13
Zika
13
Health Financing Toolbox
13
Cholera
11
Social Ethics
4
Typhoon
1
updated version: 04/10/2021
Information about vaccine administration
As countries commit to achieving universal health coverage, it is imperative to ensure that the design and delivery of palliative care services place attention on quality of care, with action needed across all domains of quality health services: effectiveness, safety, people-centredness, timeliness,...
Vaccination programmes against COVID-19 and seasonal influenza are currently being implemented in parallel in many countries. Administration of both vaccines during the same visit has potential advantages. This document presents the evidence related to coadministration of Covid-19 and influenza vacc...
Surgical site infection (SSI) is the most common postoperative complication worldwide. WHO guidelines to prevent SSI recommend alcoholic chlorhexidine skin preparation and fascial closure using triclosan-coated sutures, but called for assessment of both interventions in low-resource settings. This s...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Testing men for HIV during their partner’s pregnancy can guide couples-based HIV prevention and treatment, but testing rates remain low. We investigated a combination approach, using evidence-based strategies, to increase HIV testing in male partners of HIV-positive and HIV-negative ...
This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
Overview
16 Dec 2021. This interim guidance pertains to heterologous primary and heterologous boosting schedules of Covid-19 vaccines. It focuses on heterologous schedules combining multiple vaccine platforms (e.g. a vectored vaccine followed by an mRNA vaccine).
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
The COVID-19 Vaccine (Whole Virion Inactivated) BBV152, COVAXIN® vaccine explainer includes key information on the vaccine specific requirements.
Poster, 4 Janaury 2022
Updated Treatment Guidelines
History has shown that governments tend to deprioritize environmental commitments during times of financial and public crises as they work to mitigate immediate needs—and the age of COVID-19 has been no different. Even though human interaction with wildlife is believed to be the cause of the pande...
